According to Bizwatch, Delicious, a South Korea-based fashion B2B marketplace operator, launches its institutional investor demand test on July 23. The company plans to issue 2.2 million new shares at a price range of 5,000-7,000 won, targeting total proceeds of 11-15.4 billion won. The platform connects Dongdaemun fashion wholesalers with domestic and international retailers through its 'Shinsang Market' service.
Meanwhile, HLG Genomics, an active pharmaceutical ingredients (API) manufacturer and subsidiary of Hallim Pharmaceuticals, lists on Kosdaq on July 24 with 55.1 billion won in proceeds. The institutional investor demand test recorded a 714.52:1 competition ratio. Separately, Lemon Healthcare will lift its first mandatory holding commitment on July 21, releasing 724,123 shares held by institutional investors—equivalent to 48.27% of the 1.5 million shares allocated to institutions.